{"id":43884,"date":"2026-05-08T11:50:40","date_gmt":"2026-05-08T09:50:40","guid":{"rendered":"https:\/\/celonpharma.com\/?p=43884"},"modified":"2026-05-08T11:51:44","modified_gmt":"2026-05-08T09:51:44","slug":"representatives-of-the-european-bank-for-reconstruction-and-development-and-celon-pharma-met-to-discuss-the-progress-of-the-reduzek-project-a-strategic-investment-related-to-the-development-and-prod","status":"publish","type":"post","link":"https:\/\/celonpharma.com\/en\/representatives-of-the-european-bank-for-reconstruction-and-development-and-celon-pharma-met-to-discuss-the-progress-of-the-reduzek-project-a-strategic-investment-related-to-the-development-and-prod\/","title":{"rendered":"Representatives of the European Bank for Reconstruction and Development and Celon Pharma met to discuss the progress of the Reduzek project"},"content":{"rendered":"\n

This is strategic investment related to the development and production of GLP-1 semaglutide, used in the treatment of type II diabetes and obesity. During the meeting, the parties reviewed the current status of the project, the investment implementation schedule, and the financial cooperation concerning the construction and launch of the Celon Pharma Slovakia manufacturing facility in the \u017dilina region of Slovakia. The project constitutes one of the key elements of Celon Pharma\u2019s strategy in the field of metabolic therapies and the development of in-house manufacturing capabilities for GLP-1 drugs.<\/p>\n\n\n\n

In March 2026, Celon Pharma Slovakia, a subsidiary of Celon Pharma, signed a financing agreement with the EBRD for up to EUR 23 million. The funds are intended for the adaptation, equipment, and commissioning of a manufacturing facility dedicated to the production of the active pharmaceutical ingredient semaglutide GLP-1 under the trade name Reduzek. The financing has been divided into two tranches \u2014 up to EUR 18 million and up to EUR 5 million.<\/p>\n\n\n\n

Celon Pharma indicates that the development of manufacturing infrastructure in the GLP-1 segment may, in the coming years, support the scaling of the group\u2019s operations, revenue diversification, and expansion into international markets.<\/p>\n\n\n\n

\"\"<\/figure>\n","protected":false},"excerpt":{"rendered":"

This is strategic investment related to the development and production of GLP-1 semaglutide, used in the treatment of type II diabetes and obesity. During the meeting, the parties reviewed the current status of the project, the investment implementation schedule, and the financial cooperation concerning the construction and launch of the Celon Pharma Slovakia manufacturing facilityRead more »<\/a><\/p>\n","protected":false},"author":20,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[30],"tags":[],"class_list":["post-43884","post","type-post","status-publish","format-standard","hentry","category-general-en"],"acf":[],"yoast_head":"\nRepresentatives of the European Bank for Reconstruction and Development and Celon Pharma met to discuss the progress of the Reduzek project - Celon Pharma<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/celonpharma.com\/en\/representatives-of-the-european-bank-for-reconstruction-and-development-and-celon-pharma-met-to-discuss-the-progress-of-the-reduzek-project-a-strategic-investment-related-to-the-development-and-prod\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Representatives of the European Bank for Reconstruction and Development and Celon Pharma met to discuss the progress of the Reduzek project - Celon Pharma\" \/>\n<meta property=\"og:description\" content=\"This is strategic investment related to the development and production of GLP-1 semaglutide, used in the treatment of type II diabetes and obesity. During the meeting, the parties reviewed the current status of the project, the investment implementation schedule, and the financial cooperation concerning the construction and launch of the Celon Pharma Slovakia manufacturing facilityRead more »\" \/>\n<meta property=\"og:url\" content=\"https:\/\/celonpharma.com\/en\/representatives-of-the-european-bank-for-reconstruction-and-development-and-celon-pharma-met-to-discuss-the-progress-of-the-reduzek-project-a-strategic-investment-related-to-the-development-and-prod\/\" \/>\n<meta property=\"og:site_name\" content=\"Celon Pharma\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-08T09:50:40+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-08T09:51:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/celonpharma.com\/wp-content\/uploads\/2026\/05\/EBOR2-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1920\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Ma\u0142gorzata Siewierska\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ma\u0142gorzata Siewierska\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/representatives-of-the-european-bank-for-reconstruction-and-development-and-celon-pharma-met-to-discuss-the-progress-of-the-reduzek-project-a-strategic-investment-related-to-the-development-and-prod\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/representatives-of-the-european-bank-for-reconstruction-and-development-and-celon-pharma-met-to-discuss-the-progress-of-the-reduzek-project-a-strategic-investment-related-to-the-development-and-prod\\\/\"},\"author\":{\"name\":\"Ma\u0142gorzata Siewierska\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#\\\/schema\\\/person\\\/086a66251c93953fa818392fd883740c\"},\"headline\":\"Representatives of the European Bank for Reconstruction and Development and Celon Pharma met to discuss the progress of the Reduzek project\",\"datePublished\":\"2026-05-08T09:50:40+00:00\",\"dateModified\":\"2026-05-08T09:51:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/representatives-of-the-european-bank-for-reconstruction-and-development-and-celon-pharma-met-to-discuss-the-progress-of-the-reduzek-project-a-strategic-investment-related-to-the-development-and-prod\\\/\"},\"wordCount\":213,\"image\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/representatives-of-the-european-bank-for-reconstruction-and-development-and-celon-pharma-met-to-discuss-the-progress-of-the-reduzek-project-a-strategic-investment-related-to-the-development-and-prod\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/celonpharma.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/EBOR2-1024x768.jpg\",\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/representatives-of-the-european-bank-for-reconstruction-and-development-and-celon-pharma-met-to-discuss-the-progress-of-the-reduzek-project-a-strategic-investment-related-to-the-development-and-prod\\\/\",\"url\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/representatives-of-the-european-bank-for-reconstruction-and-development-and-celon-pharma-met-to-discuss-the-progress-of-the-reduzek-project-a-strategic-investment-related-to-the-development-and-prod\\\/\",\"name\":\"Representatives of the European Bank for Reconstruction and Development and Celon Pharma met to discuss the progress of the Reduzek project - Celon Pharma\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/representatives-of-the-european-bank-for-reconstruction-and-development-and-celon-pharma-met-to-discuss-the-progress-of-the-reduzek-project-a-strategic-investment-related-to-the-development-and-prod\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/representatives-of-the-european-bank-for-reconstruction-and-development-and-celon-pharma-met-to-discuss-the-progress-of-the-reduzek-project-a-strategic-investment-related-to-the-development-and-prod\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/celonpharma.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/EBOR2-1024x768.jpg\",\"datePublished\":\"2026-05-08T09:50:40+00:00\",\"dateModified\":\"2026-05-08T09:51:44+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#\\\/schema\\\/person\\\/086a66251c93953fa818392fd883740c\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/representatives-of-the-european-bank-for-reconstruction-and-development-and-celon-pharma-met-to-discuss-the-progress-of-the-reduzek-project-a-strategic-investment-related-to-the-development-and-prod\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/celonpharma.com\\\/en\\\/representatives-of-the-european-bank-for-reconstruction-and-development-and-celon-pharma-met-to-discuss-the-progress-of-the-reduzek-project-a-strategic-investment-related-to-the-development-and-prod\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/representatives-of-the-european-bank-for-reconstruction-and-development-and-celon-pharma-met-to-discuss-the-progress-of-the-reduzek-project-a-strategic-investment-related-to-the-development-and-prod\\\/#primaryimage\",\"url\":\"https:\\\/\\\/celonpharma.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/EBOR2-1024x768.jpg\",\"contentUrl\":\"https:\\\/\\\/celonpharma.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/EBOR2-1024x768.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/representatives-of-the-european-bank-for-reconstruction-and-development-and-celon-pharma-met-to-discuss-the-progress-of-the-reduzek-project-a-strategic-investment-related-to-the-development-and-prod\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Representatives of the European Bank for Reconstruction and Development and Celon Pharma met to discuss the progress of the Reduzek project\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/\",\"name\":\"Celon Pharma\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#\\\/schema\\\/person\\\/086a66251c93953fa818392fd883740c\",\"name\":\"Ma\u0142gorzata Siewierska\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Representatives of the European Bank for Reconstruction and Development and Celon Pharma met to discuss the progress of the Reduzek project - Celon Pharma","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/celonpharma.com\/en\/representatives-of-the-european-bank-for-reconstruction-and-development-and-celon-pharma-met-to-discuss-the-progress-of-the-reduzek-project-a-strategic-investment-related-to-the-development-and-prod\/","og_locale":"en_US","og_type":"article","og_title":"Representatives of the European Bank for Reconstruction and Development and Celon Pharma met to discuss the progress of the Reduzek project - Celon Pharma","og_description":"This is strategic investment related to the development and production of GLP-1 semaglutide, used in the treatment of type II diabetes and obesity. During the meeting, the parties reviewed the current status of the project, the investment implementation schedule, and the financial cooperation concerning the construction and launch of the Celon Pharma Slovakia manufacturing facilityRead more »","og_url":"https:\/\/celonpharma.com\/en\/representatives-of-the-european-bank-for-reconstruction-and-development-and-celon-pharma-met-to-discuss-the-progress-of-the-reduzek-project-a-strategic-investment-related-to-the-development-and-prod\/","og_site_name":"Celon Pharma","article_published_time":"2026-05-08T09:50:40+00:00","article_modified_time":"2026-05-08T09:51:44+00:00","og_image":[{"width":2560,"height":1920,"url":"https:\/\/celonpharma.com\/wp-content\/uploads\/2026\/05\/EBOR2-scaled.jpg","type":"image\/jpeg"}],"author":"Ma\u0142gorzata Siewierska","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Ma\u0142gorzata Siewierska","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/celonpharma.com\/en\/representatives-of-the-european-bank-for-reconstruction-and-development-and-celon-pharma-met-to-discuss-the-progress-of-the-reduzek-project-a-strategic-investment-related-to-the-development-and-prod\/#article","isPartOf":{"@id":"https:\/\/celonpharma.com\/en\/representatives-of-the-european-bank-for-reconstruction-and-development-and-celon-pharma-met-to-discuss-the-progress-of-the-reduzek-project-a-strategic-investment-related-to-the-development-and-prod\/"},"author":{"name":"Ma\u0142gorzata Siewierska","@id":"https:\/\/celonpharma.com\/en\/#\/schema\/person\/086a66251c93953fa818392fd883740c"},"headline":"Representatives of the European Bank for Reconstruction and Development and Celon Pharma met to discuss the progress of the Reduzek project","datePublished":"2026-05-08T09:50:40+00:00","dateModified":"2026-05-08T09:51:44+00:00","mainEntityOfPage":{"@id":"https:\/\/celonpharma.com\/en\/representatives-of-the-european-bank-for-reconstruction-and-development-and-celon-pharma-met-to-discuss-the-progress-of-the-reduzek-project-a-strategic-investment-related-to-the-development-and-prod\/"},"wordCount":213,"image":{"@id":"https:\/\/celonpharma.com\/en\/representatives-of-the-european-bank-for-reconstruction-and-development-and-celon-pharma-met-to-discuss-the-progress-of-the-reduzek-project-a-strategic-investment-related-to-the-development-and-prod\/#primaryimage"},"thumbnailUrl":"https:\/\/celonpharma.com\/wp-content\/uploads\/2026\/05\/EBOR2-1024x768.jpg","articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/celonpharma.com\/en\/representatives-of-the-european-bank-for-reconstruction-and-development-and-celon-pharma-met-to-discuss-the-progress-of-the-reduzek-project-a-strategic-investment-related-to-the-development-and-prod\/","url":"https:\/\/celonpharma.com\/en\/representatives-of-the-european-bank-for-reconstruction-and-development-and-celon-pharma-met-to-discuss-the-progress-of-the-reduzek-project-a-strategic-investment-related-to-the-development-and-prod\/","name":"Representatives of the European Bank for Reconstruction and Development and Celon Pharma met to discuss the progress of the Reduzek project - Celon Pharma","isPartOf":{"@id":"https:\/\/celonpharma.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/celonpharma.com\/en\/representatives-of-the-european-bank-for-reconstruction-and-development-and-celon-pharma-met-to-discuss-the-progress-of-the-reduzek-project-a-strategic-investment-related-to-the-development-and-prod\/#primaryimage"},"image":{"@id":"https:\/\/celonpharma.com\/en\/representatives-of-the-european-bank-for-reconstruction-and-development-and-celon-pharma-met-to-discuss-the-progress-of-the-reduzek-project-a-strategic-investment-related-to-the-development-and-prod\/#primaryimage"},"thumbnailUrl":"https:\/\/celonpharma.com\/wp-content\/uploads\/2026\/05\/EBOR2-1024x768.jpg","datePublished":"2026-05-08T09:50:40+00:00","dateModified":"2026-05-08T09:51:44+00:00","author":{"@id":"https:\/\/celonpharma.com\/en\/#\/schema\/person\/086a66251c93953fa818392fd883740c"},"breadcrumb":{"@id":"https:\/\/celonpharma.com\/en\/representatives-of-the-european-bank-for-reconstruction-and-development-and-celon-pharma-met-to-discuss-the-progress-of-the-reduzek-project-a-strategic-investment-related-to-the-development-and-prod\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/celonpharma.com\/en\/representatives-of-the-european-bank-for-reconstruction-and-development-and-celon-pharma-met-to-discuss-the-progress-of-the-reduzek-project-a-strategic-investment-related-to-the-development-and-prod\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/celonpharma.com\/en\/representatives-of-the-european-bank-for-reconstruction-and-development-and-celon-pharma-met-to-discuss-the-progress-of-the-reduzek-project-a-strategic-investment-related-to-the-development-and-prod\/#primaryimage","url":"https:\/\/celonpharma.com\/wp-content\/uploads\/2026\/05\/EBOR2-1024x768.jpg","contentUrl":"https:\/\/celonpharma.com\/wp-content\/uploads\/2026\/05\/EBOR2-1024x768.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/celonpharma.com\/en\/representatives-of-the-european-bank-for-reconstruction-and-development-and-celon-pharma-met-to-discuss-the-progress-of-the-reduzek-project-a-strategic-investment-related-to-the-development-and-prod\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/celonpharma.com\/en\/"},{"@type":"ListItem","position":2,"name":"Representatives of the European Bank for Reconstruction and Development and Celon Pharma met to discuss the progress of the Reduzek project"}]},{"@type":"WebSite","@id":"https:\/\/celonpharma.com\/en\/#website","url":"https:\/\/celonpharma.com\/en\/","name":"Celon Pharma","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/celonpharma.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/celonpharma.com\/en\/#\/schema\/person\/086a66251c93953fa818392fd883740c","name":"Ma\u0142gorzata Siewierska"}]}},"_links":{"self":[{"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/posts\/43884","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/users\/20"}],"replies":[{"embeddable":true,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/comments?post=43884"}],"version-history":[{"count":2,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/posts\/43884\/revisions"}],"predecessor-version":[{"id":43886,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/posts\/43884\/revisions\/43886"}],"wp:attachment":[{"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/media?parent=43884"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/categories?post=43884"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/tags?post=43884"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}